Mirapex - 0597-0116-30 - (pramipexole dihydrochloride)

Alphabetical Index


Drug Information of Mirapex

Product NDC: 0597-0116
Proprietary Name: Mirapex
Non Proprietary Name: pramipexole dihydrochloride
Active Ingredient(s): 4.5    mg/1 & nbsp;   pramipexole dihydrochloride
Administration Route(s): ORAL
Dosage Form(s): TABLET, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Mirapex

Product NDC: 0597-0116
Labeler Name: Boehringer Ingelheim Pharmaceuticals, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022421
Marketing Category: NDA
Start Marketing Date: 20100222

Package Information of Mirapex

Package NDC: 0597-0116-30
Package Description: 1 BOTTLE, PLASTIC in 1 CARTON (0597-0116-30) > 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC

NDC Information of Mirapex

NDC Code 0597-0116-30
Proprietary Name Mirapex
Package Description 1 BOTTLE, PLASTIC in 1 CARTON (0597-0116-30) > 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
Product NDC 0597-0116
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name pramipexole dihydrochloride
Dosage Form Name TABLET, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20100222
Marketing Category Name NDA
Labeler Name Boehringer Ingelheim Pharmaceuticals, Inc.
Substance Name PRAMIPEXOLE DIHYDROCHLORIDE
Strength Number 4.5
Strength Unit mg/1
Pharmaceutical Classes Dopamine Agonists [MoA],Nonergot Dopamine Agonist [EPC]

Complete Information of Mirapex


General Information